SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : FAMH - FIRAMADA Staffing Services -- Ignore unavailable to you. Want to Upgrade?


To: JOEY who wrote (4362)3/1/1998 5:07:00 PM
From: Jane4IceCream  Read Replies (1) | Respond to of 27968
 
JAKE,

Great Post!

I can picture those brand new sneakers on your feet....

The one thing I can contribute (at least from my own experiences) is to go with your instincts. No two people think exactly alike and that is why this stock is alittle different type of investment than what I am used too.

I usually trade in and out of BB's quickly depending on their charts and momentum. Just this past week I have taken advantage of momentum rides in MDIN, HNLY, ADOT and USWB. Have already purchased back shares in 2 of the above 4 at lower prices Friday.

I am patient with FAMH, though for me, my target is not long term. I will take my profits and run as there are always ample opportunities out there.

Have some candy

Jane



To: JOEY who wrote (4362)3/1/1998 7:34:00 PM
From: Woody  Read Replies (1) | Respond to of 27968
 
Good, thoughtful post Jake.



To: JOEY who wrote (4362)3/2/1998 2:50:00 AM
From: JIN CHUN  Respond to of 27968
 
Jake, I wholeheartedly agree with you. As you can see from my previous response to LE, when you look at other companies in the same industry, the valuations should, IMO, put FAMH at least over $1.00/share, and when you look at STFF, which I had detailed previously, the same valuation would put FAMH much higher, especially when you consider the growth that the company has achieved since any thread on FAMH has been active. In the STFF example, earnings of just .01 eps would make FAMH fairly valued at current prices. Multiply that by their future earnings potential and would anyone really be able to say that they are overvalued?

There has been a lot of talk about future dilution, the credit line, etc. My money, obviously, is on the assumption that the percentage of dilution, if any, will be far outweighed by the increase in revenue and eps. Why? Look at the Myriad deal. It diluted the number of shares by less than 5 percent while bringing in at least .05 eps for '98.

Once again, you would need more than your feet and your hands to count the number of companies that are trading over $1, $2, even $3 a share which either have negative earnings or do not yet have a product, or worse, are banking on a speculative future product that has R&D costs that will probably never exceed market potential. LE mentioned CVIA before. Although I am sympathetic to that company and the efforts of the CEO, let's face it: it had no revenue and was only a public shell. Firamada has grown through acquisition and if any would like to place a gentlemen's bet that they will have positive earnings in '98 than I will take them up on it.

Jin.